We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA API Shipment Refusal Prompts Lawsuit Impacting Border Control
FDA API Shipment Refusal Prompts Lawsuit Impacting Border Control
The FDA’s unusual demand that an importer of active pharmaceutical ingredients (API) list the distributors that might sell finished product created with the API has sparked a lawsuit that could further complicate U.S. border control processes.
